Earl M. Collier Jr.
Executive Vice President, GENZYME CORP.
Companies
- CAPRICOR THERAPEUTICS, INC.Board member Dec 2, 2013 to now1
- TesaroBoard member Jun 4, 2014 to Jan 22, 20192
- deCODE geneticsBoard member Jul 18, 2006 to Jul 31, 20093
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- CAPRICOR THERAPEUTICS, INC. CAPR57,606 shares4$382.2K at $6.63Feb 27, 2025
As of each latest filing. The line shows shares held over time.
Recent filings
- Feb 27, 2025Exercised options 750 shares at $1.39 of CAPRICOR THERAPEUTICS, INC.4
- Apr 23, 2024Exercised options 30,000 shares at $1.39 of CAPRICOR THERAPEUTICS, INC.5
- Oct 10, 2023Bought 10,000 shares at $2.83 of CAPRICOR THERAPEUTICS, INC.6
- Feb 14, 2023Exercised options 1,401 shares at $1.39 of CAPRICOR THERAPEUTICS, INC.7
- Mar 8, 2022Exercised options 15,455 shares at $1.39 of CAPRICOR THERAPEUTICS, INC.8
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2SEC EDGARTesaro, Board member
- 3SEC EDGARdeCODE genetics, Board member
- 4
- 5SEC EDGARForm 4 filed Apr 25, 2024
- 6SEC EDGARForm 4 filed Oct 12, 2023
- 7SEC EDGARForm 4 filed Feb 15, 2023
- 8SEC EDGARForm 4 filed Mar 9, 2022